General Information of This Drug (ID: DMXDHHH)

Drug Name
Mesna   DMXDHHH
Synonyms Mesnex; Mexan; Mitexan; Uromitexan; Mesna, Shionogi; S-7878; 2-mercaptoethane sulfonate
Indication
Disease Entry ICD 11 Status REF
Testicular germ cell tumor N.A. Approved [1]
Urinary dysfunction GC2Z Approved [2]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Mesna + Idarubicin DCM3D1D Idarubicin Glioblastoma? (Cell Line: T98G) [3]
------------------------------------------------------------------------------------
1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Cyclophosphamide + Mesna DC009BJ Cyclophosphamide Leukemia [4]
------------------------------------------------------------------------------------

References

1 Mesna FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 ClinicalTrials.gov (NCT00578461) T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE